Literature DB >> 8888726

Jejunal water and electrolyte transport in human cryptosporidiosis.

P Kelly1, A V Thillainayagam, J Smithson, J B Hunt, A Forbes, B G Gazzard, M J Farthing.   

Abstract

Cryptosporidiosis may have severe clinical consequences in both immunocompromised and immunocompetent individuals. However, pathophysiological mechanisms that are responsible for diarrhea are poorly understood. We performed jejunal perfusion studies in patients with human immunodeficiency virus-related cryptosporidial diarrhea to measure water and electrolyte transport in vivo. Five patients with human immunodeficiency virus-related cryptosporidiosis and nine healthy volunteers were studied using a triple-lumen steady-state jejunal perfusion technique. Stool volume measurement and distal duodenal biopsy showed that the patients had diarrhea (600-1500 ml/24 hr) and morphological abnormalities of small intestinal mucosa. Net water, sodium, and chloride movement in the jejunum was not significantly different from healthy controls. In these patients with watery diarrhea and morphological mucosal abnormalities, we found no evidence that cryptosporidial diarrhea was due to a secretory state in the proximal small intestine. We conclude that diarrhea may be due to secretion of electrolytes and water efflux more distally or to other abnormalities of gastrointestinal function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888726     DOI: 10.1007/bf02093615

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

Review 1.  Epidemiological aspects of human cryptosporidiosis.

Authors:  D P Casemore
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

2.  Natural history of AIDS related sclerosing cholangitis: a study of 20 cases.

Authors:  A Forbes; C Blanshard; B Gazzard
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

3.  Small intestinal injury and parasitic diseases in AIDS.

Authors:  D P Kotler; A Francisco; F Clayton; J V Scholes; J M Orenstein
Journal:  Ann Intern Med       Date:  1990-09-15       Impact factor: 25.391

4.  The natural history of cryptosporidial diarrhoea in HIV-infected patients.

Authors:  I McGowan; A S Hawkins; I V Weller
Journal:  AIDS       Date:  1993-03       Impact factor: 4.177

5.  Intestinal protozoa and epithelial cell kinetics, structure and function.

Authors:  A Buret; D G Gall; P N Nation; M E Olson
Journal:  Parasitol Today       Date:  1990-12

6.  Cryptosporidial diarrhoea in AIDS and its treatment.

Authors:  G M Connolly; M S Dryden; D C Shanson; B G Gazzard
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

7.  Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa.

Authors:  K Mølbak; N Højlyng; A Gottschau; J C Sá; L Ingholt; A P da Silva; P Aaby
Journal:  BMJ       Date:  1993-08-14

8.  Pathogenesis of intestinal cryptosporidiosis in conventional and gnotobiotic piglets.

Authors:  J Vítovec; B Koudela
Journal:  Vet Parasitol       Date:  1992-06       Impact factor: 2.738

9.  Prostanoids inhibit intestinal NaCl absorption in experimental porcine cryptosporidiosis.

Authors:  R A Argenzio; J Lecce; D W Powell
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

10.  Diarrhoea and malabsorption in acquired immune deficiency syndrome: a study of four cases with special emphasis on opportunistic protozoan infestations.

Authors:  R Modigliani; C Bories; Y Le Charpentier; M Salmeron; B Messing; A Galian; J C Rambaud; A Lavergne; B Cochand-Priollet; I Desportes
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

View more
  1 in total

1.  Substance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis.

Authors:  Julio Hernandez; Andrew Lackner; Pyone Aye; Kakali Mukherjee; David J Tweardy; Mary-Ann Mastrangelo; Joel Weinstock; Jeffrey Griffiths; Melinda D'Souza; Shantu Dixit; Prema Robinson
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.